Endocrine-Related Cancer 16
(2)
319
-323
DOI: 10.1677/ERC-08-0305
Copyright © 2009 by the Society for Endocrinology
Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation
Qun Zhou1,
Patrick G Shaw2,3 and
Nancy E Davidson2,3
1 Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
2 Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
3 University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue Suite 500, Pittsburgh, Pennsylvania 15232, USA
(Correspondence should be addressed to N E Davidson; Email: davidsonne{at}upmc.edu)
The nuclear hormone receptor estrogen receptor
(ER
) promotes cellular growth through ligand-dependent activation of specific target genes, a process which is targeted in the treatment of ER
-expressing breast cancers. ER
activity is regulated at the protein level by post-translational modifications including phosphorylation and acetylation. A study now shows that ER
can also be directly methylated at lysine 302 (K302) by SET7, a histone methyltransferase that is known to monomethylate H3K4 and is associated with transcriptional activation. It was shown that K302 methylation stabilizes ER
protein and is suggested to increase sensitivity of ER
to estrogens, enhancing transcription of estrogen response elements. Furthermore, SET7 methylation of K302 is enhanced by a breast cancer-associated mutation at K303 (K303R) in vitro. These findings provide an additional mechanism of SET7 mediated transcriptional activation, as well as potential insight into the complex regulation of ER
stability and ligand sensitivity.
Copyright © 2009 by the Society for Endocrinology.